Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development

Cell Reports

Volumn 14, Issue 1, 2016, Pages 82-92

  Luo, Xianmin ^a   Fu, Yujie ^a   Loza, Andrew J ^a   Murali, Bhavna ^a   Leahy, Kathleen M ^a   Ruhland, Megan K ^a   Gang, Margery ^a   Su, Xinming ^a   Zamani, Ali ^a   Shi, Yu ^a   Lavine, Kory J ^a   Ornitz, David M ^a,b   Weilbaecher, Katherine N ^a,b   Long, Fanxin ^a,b   Novack, Deborah V ^a,b   Faccio, Roberta ^a,b   Longmore, Gregory D ^a,b   Stewart, Sheila A ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MATRIX; BONE METASTASIS; BONE MINERALIZATION; BREAST CANCER; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; MOUSE; MOUSE MODEL; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; SENESCENCE; STROMA CELL; TUMOR MICROENVIRONMENT; TUMOR SEEDING; TUMOR VOLUME; ANIMAL; BONE TUMOR; CELL AGING; EXPERIMENTAL MAMMARY NEOPLASM; GENETICS; HUMAN; METABOLISM; METASTASIS; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BONE NEOPLASMS; CELL AGING; FEMALE; HUMANS; INTERLEUKIN-6; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OSTEOBLASTS; TUMOR MICROENVIRONMENT;

EID: 84952985171     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.016     Document Type: Article

References (36)

1. Alexander K., Hinds P.W. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence. Mol. Cell. Biol. 2001, 21:3616-3631.
2. Bakker A.D., Klein-Nulend J. Osteoblast isolation from murine calvaria and long bones. Methods Mol. Biol. 2012, 816:19-29.
3. Bavik C., Coleman I., Dean J.P., Knudsen B., Plymate S., Nelson P.S. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res. 2006, 66:794-802.
4. Coleman R.E., Rubens R.D. The clinical course of bone metastases from breast cancer. Br. J. Cancer 1987, 55:61-66.
5. Coppé J.P., Patil C.K., Rodier F., Sun Y., Muñoz D.P., Goldstein J., Nelson P.S., Desprez P.Y., Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6:2853-2868.
6. Coppé J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 2010, 5:99-118.
7. Coppé J.P., Rodier F., Patil C.K., Freund A., Desprez P.Y., Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J. Biol. Chem. 2011, 286:36396-36403.
8. Denchi E.L., de Lange T. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 2007, 448:1068-1071.
9. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 1995, 92:9363-9367.
10. Filgueira L. Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols. J. Histochem. Cytochem. 2004, 52:411-414.
11. Hall C., Krishnamurthy S., Lodhi A., Bhattacharyya A., Anderson A., Kuerer H., Bedrosian I., Singh B., Lucci A. Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer 2012, 118:342-348.
12. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
13. Hiratsuka S., Nakamura K., Iwai S., Murakami M., Itoh T., Kijima H., Shipley J.M., Senior R.M., Shibuya M. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002, 2:289-300.
14. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 127:1755-1766.
15. Krtolica A., Parrinello S., Lockett S., Desprez P.Y., Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA 2001, 98:12072-12077.
16. Kuilman T., Michaloglou C., Vredeveld L.C., Douma S., van Doorn R., Desmet C.J., Aarden L.A., Mooi W.J., Peeper D.S. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031.
17. Lavine K.J., Schmid G.J., Smith C.S., Ornitz D.M. Novel tool to suppress cell proliferation in vivo demonstrates that myocardial and coronary vascular growth represent distinct developmental programs. Dev. Dyn. 2008, 237:713-724.
18. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 2012, 13:27-38.
19. Lucci A., Hall C.S., Lodhi A.K., Bhattacharyya A., Anderson A.E., Xiao L., Bedrosian I., Kuerer H.M., Krishnamurthy S. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol. 2012, 13:688-695.
20. McHugh K.P., Hodivala-Dilke K., Zheng M.H., Namba N., Lam J., Novack D., Feng X., Ross F.P., Hynes R.O., Teitelbaum S.L. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 2000, 105:433-440.
21. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59:5002-5011.
22. Parrinello S., Coppe J.P., Krtolica A., Campisi J. Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 2005, 118:485-496.
23. Pazolli E., Luo X., Brehm S., Carbery K., Chung J.J., Prior J.L., Doherty J., Demehri S., Salavaggione L., Piwnica-Worms D., Stewart S.A. Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res. 2009, 69:1230-1239.
24. Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 2009, 9:285-293.
25. Reilly R.T., Gottlieb M.B., Ercolini A.M., Machiels J.P., Kane C.E., Okoye F.I., Muller W.J., Dixon K.H., Jaffee E.M. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice. Cancer Res. 2000, 60:3569-3576.
26. Rodan G.A., Martin T.J. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif. Tissue Int. 1981, 33:349-351.
27. Rodier F., Campisi J. Four faces of cellular senescence. J. Cell Biol. 2011, 192:547-556.
28. Ruhland M.K., Coussens L.M., Stewart S.A. Senescence and cancer: an evolving inflammatory paradox. Biochim Biophys Acta 2015, Published online October 8, 2015. 10.1016/j.bbcan.2015.10.001.
29. Sceneay J., Chow M.T., Chen A., Halse H.M., Wong C.S.F., Andrews D.M., Sloan E.K., Parker B.S., Bowtell D.D., Smyth M.J., et al. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 2012, 72:3906-3911.
30. Sceneay J., Smyth M.J., Möller A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 2013, 32:449-464.
31. Schafer Z.T., Brugge J.S. IL-6 involvement in epithelial cancers. J. Clin. Invest. 2007, 117:3660-3663.
32. Taichman R.S., Cooper C., Keller E.T., Pienta K.J., Taichman N.S., McCauley L.K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002, 62:1832-1837.
33. Tawara K., Oxford J.T., Jorcyk C.L. Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag. Res. 2011, 3:177-189.
34. Udagawa N., Takahashi N., Katagiri T., Tamura T., Wada S., Findlay D.M., Martin T.J., Hirota H., Taga T., Kishimoto T., Suda T. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J. Exp. Med. 1995, 182:1461-1468.
35. Weilbaecher K.N., Guise T.A., McCauley L.K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer 2011, 11:411-425.
36. Zheng B., Zhang Z., Black C.M., de Crombrugghe B., Denton C.P. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis. Am. J. Pathol. 2002, 160:1609-1617.